Skip to content
TrialScanner

NCT05184088

Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis

Phase 3CompletedLNTHLead

Registry record

Lead sponsor
Lantheus Germany GmbH
Conditions
Cardiac Amyloidosis; AL Amyloidosis; ATTR Amyloidosis
Primary completion
Apr 21, 2026Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05184088 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05184088: Efficacy of [18F]Florbetaben... | TrialScanner